Access cutting-edge copd treatment through this clinical trial at a research site in Mesa. Study-provided care at no cost to qualified participants.
Access copd specialists in Mesa at no cost
This study follows strict safety protocols and ethical guidelines
All study-related copd treatment provided free
This study will evaluate the effect of triple ICS/LAMA/LABA therapy with BGF MDI 320/14.4/9.6 μg on cardiopulmonary outcomes relative to LAMA/LABA therapy with GFF MDI 14.4/9.6 μg in a population with COPD and elevated cardiopulmonary risk.
Sponsor: AstraZeneca
Check if you qualify for this copd clinical trial in Mesa, AZ
If you're searching for copd treatment options in Mesa, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Mesa research site is actively enrolling participants for this clinical trial. You'll receive care from experienced copd specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.